Staar Surgical (STAA) Cash from Investing Activities (2016 - 2026)
Staar Surgical's Cash from Investing Activities history spans 17 years, with the latest figure at -$19.4 million for Q1 2026.
- For Q1 2026, Cash from Investing Activities changed 0.41% year-over-year to -$19.4 million; the TTM value through Jan 2026 reached $46.3 million, up 178.25%, while the annual FY2026 figure was $46.3 million, 178.25% up from the prior year.
- Cash from Investing Activities reached -$19.4 million in Q1 2026 per STAA's latest filing, down from $5.3 million in the prior quarter.
- In the past five years, Cash from Investing Activities ranged from a high of $35.4 million in Q1 2025 to a low of -$101.8 million in Q3 2022.
- Average Cash from Investing Activities over 5 years is -$5.9 million, with a median of $1.4 million recorded in 2022.
- Peak YoY movement for Cash from Investing Activities: tumbled 3011.79% in 2022, then skyrocketed 491.22% in 2023.
- A 5-year view of Cash from Investing Activities shows it stood at -$46.7 million in 2022, then skyrocketed by 147.95% to $22.4 million in 2023, then tumbled by 187.02% to -$19.5 million in 2024, then surged by 127.1% to $5.3 million in 2025, then plummeted by 467.5% to -$19.4 million in 2026.
- Per Business Quant, the three most recent readings for STAA's Cash from Investing Activities are -$19.4 million (Q1 2026), $5.3 million (Q3 2025), and $25.1 million (Q2 2025).